Trial · NCT04410991
Adverse events192
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 192
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Covid-19 | Infections and infestations | Teriflunomide 14 mg | 115 | 451 | 131 |
| other | Covid-19 | Infections and infestations | Tolebrutinib 60 mg | 106 | 447 | 126 |
| other | Influenza | Infections and infestations | Teriflunomide 14 mg | 25 | 451 | 35 |
| other | Influenza | Infections and infestations | Tolebrutinib 60 mg | 27 | 447 | 33 |
| other | Nasopharyngitis | Infections and infestations | Teriflunomide 14 mg | 64 | 451 | 97 |
| other | Nasopharyngitis | Infections and infestations | Tolebrutinib 60 mg | 60 | 447 | 102 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Teriflunomide 14 mg | 36 | 451 | 49 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Tolebrutinib 60 mg | 31 | 447 | 43 |
| other | Urinary Tract Infection | Infections and infestations | Teriflunomide 14 mg | 30 | 451 | 43 |
| other | Urinary Tract Infection | Infections and infestations | Tolebrutinib 60 mg | 25 | 447 | 35 |
| other | Viral Upper Respiratory Tract Infection | Infections and infestations | Teriflunomide 14 mg | 24 | 451 | 26 |
| other | Viral Upper Respiratory Tract Infection | Infections and infestations | Tolebrutinib 60 mg | 19 | 447 | 28 |
| other | Neutropenia | Blood and lymphatic system disorders | Teriflunomide 14 mg | 34 | 451 | 72 |
| other | Neutropenia | Blood and lymphatic system disorders | Tolebrutinib 60 mg | 10 | 447 | 14 |
| other | Anxiety | Psychiatric disorders | Teriflunomide 14 mg | 28 | 451 | 33 |
| other | Anxiety | Psychiatric disorders | Tolebrutinib 60 mg | 24 | 447 | 25 |
| other | Headache | Nervous system disorders | Teriflunomide 14 mg | 54 | 451 | 64 |
| other | Headache | Nervous system disorders | Tolebrutinib 60 mg | 61 | 447 | 82 |
| other | Paraesthesia | Nervous system disorders | Teriflunomide 14 mg | 25 | 451 | 30 |
| other | Paraesthesia | Nervous system disorders | Tolebrutinib 60 mg | 16 | 447 | 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04410991/events